Literature DB >> 23675911

New substituted benzimidazole derivatives: a patent review (2010 - 2012).

Fan Fei1, Zhiming Zhou.   

Abstract

INTRODUCTION: Benzimidazole is a heterocyclic aromatic system, which is part of some natural and many synthetic compounds. A large number of benzimidazoles and its derivatives are found to be biologically active against many diseases. Researchers around the world are paying greater attention to and showing increasing interests in this field. AREAS COVERED: Areas covered in this paper include a review of the synthesis, biological effects and mechanisms of benzimidazole derivatives in the past 2 years, based on literature and patents. The patent databases SciFinder and esp@cenet were used to locate patent applications that were published between 2010 to present. Information from articles published is also included. The current state and problems are also discussed. EXPERT OPINION: Benzimidazole derivatives possess a broad spectrum of biological activities, whose scopes of treatment ranging from ordinary antimicrobial activities to world's most deadly diseases. However, challenges such as drug resistance, relatively little knowledge of structure of receptors and rare convenient methods for synthesis of benzimidazoles still exist.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23675911     DOI: 10.1517/13543776.2013.800857

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  3 in total

1.  Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways.

Authors:  Erkan Kahraman; Erdem Göker
Journal:  Mol Biol Rep       Date:  2022-02-28       Impact factor: 2.742

2.  Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.

Authors:  Hatem A Abdel-Aziz; Wagdy M Eldehna; Hazem Ghabbour; Ghada H Al-Ansary; Areej M Assaf; Abdullah Al-Dhfyan
Journal:  Int J Mol Sci       Date:  2016-07-29       Impact factor: 5.923

3.  Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach.

Authors:  Vidyasrilekha Yele; Bharat Kumar Reddy Sanapalli; Afzal Azam Mohammed
Journal:  Chem Zvesti       Date:  2021-10-18       Impact factor: 2.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.